Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from Butterfly Network ( (BFLY) ).
On August 1, 2025, Heather C. Getz stepped down as Butterfly Network‘s Executive Vice President and Chief Financial & Operations Officer, transitioning to an advisory role until March 2026. Megan Carlson, the Chief Accounting Officer, has been appointed as Interim Chief Financial Officer. The company has begun the search for a permanent CFO. This leadership transition is not due to any disagreements with the company. In the second quarter of 2025, Butterfly Network reported its highest quarterly revenue of $23.4 million and gross margins of 64%, marking a significant achievement in its financial performance. The company is focused on scaling its core business and exploring new revenue streams, with upcoming launches of advanced AI software and technology innovations, positioning itself as a leader in handheld ultrasound technology.
The most recent analyst rating on (BFLY) stock is a Buy with a $3.75 price target. To see the full list of analyst forecasts on Butterfly Network stock, see the BFLY Stock Forecast page.
Spark’s Take on BFLY Stock
According to Spark, TipRanks’ AI Analyst, BFLY is a Neutral.
Butterfly Network’s overall stock score reflects its financial and technical challenges, mitigated by positive developments from its latest earnings call. The company’s significant revenue growth and strategic advancements, particularly in the U.S. market, are promising. However, persistent profitability issues, negative cash flow, and bearish technical indicators weigh on the overall score.
To see Spark’s full report on BFLY stock, click here.
More about Butterfly Network
Butterfly Network, Inc. (NYSE: BFLY) is a healthcare company revolutionizing medical imaging with its proprietary Ultrasound-on-Chip™ semiconductor technology and ultrasound software solutions. The company launched the world’s first handheld, single-probe, whole-body ultrasound system, Butterfly iQ, in 2018, followed by the iQ+ in 2020 and the iQ3 in 2024, each offering enhanced processing power and performance.
Average Trading Volume: 3,731,711
Technical Sentiment Signal: Sell
Current Market Cap: $422.9M
For a thorough assessment of BFLY stock, go to TipRanks’ Stock Analysis page.